Periodical
Προβολή σε EDS

A consensus statement from the Portuguese Society of Hypertension and the Portuguese Society of Cardiology for bridging the 2023-2025 hypertension Guidelines in clinical practice.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: A consensus statement from the Portuguese Society of Hypertension and the Portuguese Society of Cardiology for bridging the 2023-2025 hypertension Guidelines in clinical practice.
Συγγραφείς: Ribeiro H; Serviço de Medicina Interna, Unidade Local de Saúde de Entre Douro e Vouga. R. Dr. Cândido Pinho 5, Santa Maria da Feira, Portugal., Matos Vilela E; Serviço de Cardiologia, Unidade Local de Saúde de Gaia e Espinho. Rua Conceição Fernandes, Vila Nova de Gaia, Portugal.; Departamento de Medicina, Faculdade de Medicina da Universidade do Porto. Alameda Prof. Hernâni Monteiro, Porto, Portugal., Martos Gonçalves F; Serviço de Medicina Interna, Hospital Beatriz Ângelo, Unidade Local de Saúde Loures, Odivelas, Avenida Carlos Teixeira, 3. Loures, Portugal., Gavina C; Departamento de Medicina, Faculdade de Medicina da Universidade do Porto. Alameda Prof. Hernâni Monteiro, Porto, Portugal.; Serviço de Cardiologia, Unidade Local de Saúde de Matosinhos, Senhora da Hora, Portugal.; UnIC, Faculdade de Medicina, Universidade do Porto. Al. Prof. Hernâni Monteiro, Porto, Portugal., de Pinho R; USF Vale do Vouga, Unidade Local de Saúde Entre Douro e Vouga, São João da Madeira, Portugal.
Πηγή: Blood pressure [Blood Press] 2026 Dec; Vol. 35 (1), pp. 2624257. Date of Electronic Publication: 2026 Feb 13.
Τύπος έκδοσης: News
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9301454 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1651-1999 (Electronic) Linking ISSN: 08037051 NLM ISO Abbreviation: Blood Press Subsets: MEDLINE
Imprint Name(s): Publication: 2015- : Abingdon, Oxford : Taylor & Francis
Original Publication: Oslo : Scandinavian University Press
Ιατρικοί όροι (MeSH): Antihypertensive Agents*/therapeutic use , Hypertension*/drug therapy , Hypertension*/physiopathology , Hypertension*/therapy , Hypertension*/diagnosis , Consensus Statements as Topic*, Blood Pressure/drug effects ; Humans ; Cardiology ; Portugal ; Societies, Medical
Περίληψη: Background: Effective management of arterial hypertension remains a major global health priority. In the need to improve real-world implementation of best practices, three international organisations have released independent clinical practice guidelines: the European Society of Hypertension (ESH, 2023), the European Society of Cardiology (ESC, 2024) and the American College of Cardiology/American Heart Association (AHA/ACC, 2025).1.
Aim and Methods: This society-endorsed consensus document, jointly developed by the Portuguese Society of Hypertension and the Portuguese Society of Cardiology, aims to harmonise partially divergent hypertension guidelines into applicable recommendations. It provides a pragmatic comparative synthesis of the 2023-2025 guidelines, structured according to the M.A.P.E. framework (Measure, Assess, Prescribe, Evaluate), to support decision-making in clinical practice.
Results: Across European guidelines, there is a strong alignment in the definition of hypertension (systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg), CV risk stratification, lifestyle interventions, and first-line use of combination therapy of two drugs out of four. Divergences arise in BP classification systems, initiation thresholds, dosing strategies and target BP goals. The 2025 AHA/ACC Guidelines differ by adopting lower diagnostic and treatment thresholds (≥130/80 mmHg) and early pharmacological intervention based on individual CV risk. This consensus acknowledges differences and supports a risk-based approach grounded in randomised trial evidence, feasibility in routine clinical practice, and patient safety, recognising office BP as the basis for treatment decisions.
Conclusions: This consensus aims to reduce clinical uncertainty and optimise hypertension management in real-world practice providing clear and evidence-informed clinical recommendations.
Σχόλια: Erratum in: Blood Press. 2026 Dec;35(1):2647700. doi: 10.1080/08037051.2026.2647700.. (PMID: 41886763)
Contributed Indexing: Keywords: Blood pressure; antihypertensive drug therapy; cardiovascular disease; clinical recommendations; consensus; guidelines; hypertension; management of arterial hypertension
Local Abstract: [plain-language-summary] High blood pressure, also called hypertension, is one of the most common health problems worldwide. It greatly increases the risk of heart and kidney disease. To help doctors and patients manage hypertension effectively, several international organisations regularly update their treatment recommendations, known as clinical guidelines.This article summarises and compares the most recent guidelines from three major scientific organisations: the European Society of Hypertension (ESH, 2023), the European Society of Cardiology (ESC, 2024), and the American College of Cardiology/American Heart Association (AHA/ACC, 2025). Although these guidelines share the same goal – improving blood pressure control and preventing heart, brain and kidney complications – they differ in certain clinical details, such as when to start medication, how much to lower blood pressure, and the targets to achieve.This consensus document, developed by the Portuguese Society of Hypertension and the Portuguese Society of Cardiology, combines different guidelines on high blood pressure to offer clear and practical advice for everyday patient care.The European guidelines agree on defining hypertension as blood pressure at or above 140/90 mmHg. They also recommend lifestyle changes, regular monitoring, and the use of the same main types of blood pressure-lowering medicines. In contrast, the American guidelines use lower thresholds (from 130/80 mmHg) and encourage earlier medicine treatment in people at higher cardiovascular risk.The Portuguese consensus acknowledges these differences and supports a risk-based approach that is based on results from clinical trials, is practical for everyday care, and prioritises patient safety, using blood pressure measured in the clinic to guide treatment decisions.By bringing together European and American guidelines, this Portuguese consensus aims to reduce uncertainty for healthcare professionals and help improve the everyday management of high blood pressure through well-defined and practical recommendations.
Substance Nomenclature: 0 (Antihypertensive Agents)
Entry Date(s): Date Created: 20260129 Date Completed: 20260701 Latest Revision: 20260707
Update Code: 20260708
DOI: 10.1080/08037051.2026.2624257
PMID: 41607194
Βάση Δεδομένων: MEDLINE
FullText Text:
  Availability: 0
Header DbId: cmedm
DbLabel: MEDLINE
An: 41607194
AccessLevel: 3
PubType: Periodical
PubTypeId: serialPeriodical
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A consensus statement from the Portuguese Society of Hypertension and the Portuguese Society of Cardiology for bridging the 2023-2025 hypertension Guidelines in clinical practice.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ribeiro+H%22">Ribeiro H</searchLink>; Serviço de Medicina Interna, Unidade Local de Saúde de Entre Douro e Vouga. R. Dr. Cândido Pinho 5, Santa Maria da Feira, Portugal.<br /><searchLink fieldCode="AU" term="%22Matos+Vilela+E%22">Matos Vilela E</searchLink>; Serviço de Cardiologia, Unidade Local de Saúde de Gaia e Espinho. Rua Conceição Fernandes, Vila Nova de Gaia, Portugal.; Departamento de Medicina, Faculdade de Medicina da Universidade do Porto. Alameda Prof. Hernâni Monteiro, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Martos+Gonçalves+F%22">Martos Gonçalves F</searchLink>; Serviço de Medicina Interna, Hospital Beatriz Ângelo, Unidade Local de Saúde Loures, Odivelas, Avenida Carlos Teixeira, 3. Loures, Portugal.<br /><searchLink fieldCode="AU" term="%22Gavina+C%22">Gavina C</searchLink>; Departamento de Medicina, Faculdade de Medicina da Universidade do Porto. Alameda Prof. Hernâni Monteiro, Porto, Portugal.; Serviço de Cardiologia, Unidade Local de Saúde de Matosinhos, Senhora da Hora, Portugal.; UnIC, Faculdade de Medicina, Universidade do Porto. Al. Prof. Hernâni Monteiro, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22de+Pinho+R%22">de Pinho R</searchLink>; USF Vale do Vouga, Unidade Local de Saúde Entre Douro e Vouga, São João da Madeira, Portugal.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229301454%22">Blood pressure</searchLink> [Blood Press] 2026 Dec; Vol. 35 (1), pp. 2624257. <i>Date of Electronic Publication: </i>2026 Feb 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: News
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9301454 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1651-1999 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208037051%22">08037051 </searchLink><i>NLM ISO Abbreviation: </i>Blood Press <i>Subsets: </i>MEDLINE
– Name: PublisherInfo
  Label: Imprint Name(s)
  Group: PubInfo
  Data: <i>Publication</i>: 2015- : Abingdon, Oxford : Taylor & Francis<br /><i>Original Publication</i>: Oslo : Scandinavian University Press
– Name: SubjectMESH
  Label: MeSH Terms
  Group: Su
  Data: <searchLink fieldCode="MM" term="%22Antihypertensive+Agents%22">Antihypertensive Agents*</searchLink>/<searchLink fieldCode="MM" term="%22Antihypertensive+Agents+therapeutic+use%22">therapeutic use</searchLink> <br /><searchLink fieldCode="MM" term="%22Hypertension%22">Hypertension*</searchLink>/<searchLink fieldCode="MM" term="%22Hypertension+drug+therapy%22">drug therapy</searchLink> <br /><searchLink fieldCode="MM" term="%22Hypertension%22">Hypertension*</searchLink>/<searchLink fieldCode="MM" term="%22Hypertension+physiopathology%22">physiopathology</searchLink> <br /><searchLink fieldCode="MM" term="%22Hypertension%22">Hypertension*</searchLink>/<searchLink fieldCode="MM" term="%22Hypertension+therapy%22">therapy</searchLink> <br /><searchLink fieldCode="MM" term="%22Hypertension%22">Hypertension*</searchLink>/<searchLink fieldCode="MM" term="%22Hypertension+diagnosis%22">diagnosis</searchLink> <br /><searchLink fieldCode="MM" term="%22Consensus+Statements+as+Topic%22">Consensus Statements as Topic*</searchLink><br /><searchLink fieldCode="MH" term="%22Blood+Pressure%22">Blood Pressure</searchLink>/<searchLink fieldCode="MH" term="%22Blood+Pressure+drug+effects%22">drug effects</searchLink> ; <searchLink fieldCode="MH" term="%22Humans%22">Humans</searchLink> ; <searchLink fieldCode="MH" term="%22Cardiology%22">Cardiology</searchLink> ; <searchLink fieldCode="MH" term="%22Portugal%22">Portugal</searchLink> ; <searchLink fieldCode="MH" term="%22Societies%2C+Medical%22">Societies, Medical</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Background: Effective management of arterial hypertension remains a major global health priority. In the need to improve real-world implementation of best practices, three international organisations have released independent clinical practice guidelines: the European Society of Hypertension (ESH, 2023), the European Society of Cardiology (ESC, 2024) and the American College of Cardiology/American Heart Association (AHA/ACC, 2025).<superscript>1</superscript>.<br />Aim and Methods: This society-endorsed consensus document, jointly developed by the Portuguese Society of Hypertension and the Portuguese Society of Cardiology, aims to harmonise partially divergent hypertension guidelines into applicable recommendations. It provides a pragmatic comparative synthesis of the 2023-2025 guidelines, structured according to the M.A.P.E. framework (Measure, Assess, Prescribe, Evaluate), to support decision-making in clinical practice.<br />Results: Across European guidelines, there is a strong alignment in the definition of hypertension (systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg), CV risk stratification, lifestyle interventions, and first-line use of combination therapy of two drugs out of four. Divergences arise in BP classification systems, initiation thresholds, dosing strategies and target BP goals. The 2025 AHA/ACC Guidelines differ by adopting lower diagnostic and treatment thresholds (≥130/80 mmHg) and early pharmacological intervention based on individual CV risk. This consensus acknowledges differences and supports a risk-based approach grounded in randomised trial evidence, feasibility in routine clinical practice, and patient safety, recognising office BP as the basis for treatment decisions.<br />Conclusions: This consensus aims to reduce clinical uncertainty and optimise hypertension management in real-world practice providing clear and evidence-informed clinical recommendations.
– Name: Comment
  Label: Comments
  Group: Commnt
  Data: Erratum in: Blood Press. 2026 Dec;35(1):2647700. doi: 10.1080/08037051.2026.2647700.. (PMID: <searchLink fieldCode="PM" term="%2241886763%22">41886763)</searchLink>
– Name: SubjectMinor
  Label: Contributed Indexing
  Group:
  Data: <i>Keywords: </i>Blood pressure; antihypertensive drug therapy; cardiovascular disease; clinical recommendations; consensus; guidelines; hypertension; management of arterial hypertension<br /><i>Local Abstract: </i>[plain-language-summary] High blood pressure, also called hypertension, is one of the most common health problems worldwide. It greatly increases the risk of heart and kidney disease. To help doctors and patients manage hypertension effectively, several international organisations regularly update their treatment recommendations, known as clinical guidelines.This article summarises and compares the most recent guidelines from three major scientific organisations: the European Society of Hypertension (ESH, 2023), the European Society of Cardiology (ESC, 2024), and the American College of Cardiology/American Heart Association (AHA/ACC, 2025). Although these guidelines share the same goal – improving blood pressure control and preventing heart, brain and kidney complications – they differ in certain clinical details, such as when to start medication, how much to lower blood pressure, and the targets to achieve.This consensus document, developed by the Portuguese Society of Hypertension and the Portuguese Society of Cardiology, combines different guidelines on high blood pressure to offer clear and practical advice for everyday patient care.The European guidelines agree on defining hypertension as blood pressure at or above 140/90 mmHg. They also recommend lifestyle changes, regular monitoring, and the use of the same main types of blood pressure-lowering medicines. In contrast, the American guidelines use lower thresholds (from 130/80 mmHg) and encourage earlier medicine treatment in people at higher cardiovascular risk.The Portuguese consensus acknowledges these differences and supports a risk-based approach that is based on results from clinical trials, is practical for everyday care, and prioritises patient safety, using blood pressure measured in the clinic to guide treatment decisions.By bringing together European and American guidelines, this Portuguese consensus aims to reduce uncertainty for healthcare professionals and help improve the everyday management of high blood pressure through well-defined and practical recommendations.
– Name: NumberCAS
  Label: Substance Nomenclature
  Group: ID
  Data: 0 (Antihypertensive Agents)
– Name: DateEntry
  Label: Entry Date(s)
  Group: Date
  Data: <i>Date Created: </i>20260129 <i>Date Completed: </i>20260701 <i>Latest Revision: </i>20260707
– Name: DateUpdate
  Label: Update Code
  Group: Date
  Data: 20260708
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.1080/08037051.2026.2624257
– Name: AN
  Label: PMID
  Group: ID
  Data: 41607194
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cmedm&AN=41607194
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/08037051.2026.2624257
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2624257
    Subjects:
      – SubjectFull: Blood Pressure drug effects
        Type: general
      – SubjectFull: Humans
        Type: general
      – SubjectFull: Cardiology
        Type: general
      – SubjectFull: Portugal
        Type: general
      – SubjectFull: Societies, Medical
        Type: general
      – SubjectFull: Antihypertensive Agents therapeutic use
        Type: general
      – SubjectFull: Hypertension drug therapy
        Type: general
      – SubjectFull: Hypertension physiopathology
        Type: general
      – SubjectFull: Hypertension therapy
        Type: general
      – SubjectFull: Hypertension diagnosis
        Type: general
      – SubjectFull: Consensus Statements as Topic
        Type: general
    Titles:
      – TitleFull: A consensus statement from the Portuguese Society of Hypertension and the Portuguese Society of Cardiology for bridging the 2023-2025 hypertension Guidelines in clinical practice.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ribeiro H
      – PersonEntity:
          Name:
            NameFull: Matos Vilela E
      – PersonEntity:
          Name:
            NameFull: Martos Gonçalves F
      – PersonEntity:
          Name:
            NameFull: Gavina C
      – PersonEntity:
          Name:
            NameFull: de Pinho R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2026 Dec
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1651-1999
          Numbering:
            – Type: volume
              Value: 35
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood pressure
              Type: main
ResultId 1